Biotech

All Articles

Pfizer, Valneva show lyme disease shot successful for 2nd enhancer

.Pfizer and also Valneva might have regarding 2 additional years to stand by before they produce the...

Fierce Biotech Managing Editor Ayla Ellison Chats Shop with Michelle Benz on the Future of Biotech.

.Allow's dive into a talk along with Ayla Ellison, Strong Biotech Editor-in-Chief and also Michelle ...

New information show how Bayer's asundexian fell short to avoid strokes

.Bayer suspended the period 3 test for its variable XIa prevention asundexian behind time in 2014 af...

Sanofi's tolebrutinib neglects 2 of 3 late-stage MS tests

.Sanofi is actually still set on taking its several sclerosis (MS) med tolebrutinib to the FDA, exec...

Galapagos' stockpile as fund presents intent to form its evolution

.Galapagos is actually coming under additional stress from real estate investors. Having constructed...

Cell- focused Sana gathers initial CSO-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our roundup of substantial management hirings, firings as we...

Allist pays off Jacobio $21M, landing job in Chinese KRAS nationality

.Shanghai Allist Pharmaceuticals has bought itself a starring role in China's KRAS market, paying Ja...

ReNeuron leaving AIM substitution after overlooking fundraising goal

.ReNeuron has actually signed up with the long listing of biotechs to leave Greater london's AIM sto...

MBX files for IPO to take challenger to Ascendis right into phase 3

.MBX Biosciences has actually added to the recent flurry of IPO filings. The biotech, which submitte...

FDA extends probe in to Lykos' MDMA trials: WSJ

.For Lykos Rehabs as well as the firm's prospective MDMA-assisted treatment for trauma (POST-TRAUMAT...